Evaluate the Efficacy and Safety of ACTIQ in Patients With Cancer and Breakthrough Pain

Clinical trial NCT00236145 · COMPLETED

Trial details

NCT number: NCT00236145
Sponsor: Cephalon
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Breakthrough Pain

Start date: 2004-06-01
Primary completion: 2005-08-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.